Clinical trials for Carcinoid syndrome

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Carcinoid syndrome. For all clinical trials, go to clinical trials search

This list shows clinical trials for Carcinoid syndrome

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Carcinoid syndrome
Title Recruitment status Location
Telotristat Etiprate - Expanded Treatment for Patients With Carcinoid Syndrome Symptoms Not recruiting United Kingdom
A Research Study of the Efficacy and Safety of Telotristat Etiprate for Carcinoid Syndrome Patients, Who Do Not Respond to Somatostatin Analogue Therapy Not Recruiting United Kingdom
TELESTAR (Telotristat Etiprate for Somatostatin Analogue Not Adequately Controlled Carcinoid Syndrome) Not recruiting United Kingdom
An Open-label Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]-Telotristat Etiprate in Males Not recruiting United Kingdom
ESTUDIO EN FASE II ABIERTO, ADAPTATIVO, MULTICÉNTRICO, CON AUMENTO Y AJUSTE DE LA DOSIS PARA EVALUAR LA SEGURIDAD Y LA EFICACIA DE LA ADMINISTRACIÓN SUBCUTÁNEA REPETIDA DE DISTINTAS DOSIS DE BIM 23A760 EN PACIENTES CON SÍNDROME CARCINOIDE. Phase II, open, adaptive, dose escalating, multicentre titration study to assess the efficacy and safety of repeated subcutaneous administration of different doses of BIM 23A760 in patients with carcinoid syndrome Not Recruiting United Kingdom
Effects of Serotonin Excess on Bone in Carcinoid Syndrome Not recruiting United Kingdom
Study to Assess the Efficacy and Safety of Different Doses of BIM 23A760 in Patients With Carcinoid Syndrome Not recruiting United Kingdom
Phase II, open, adaptive, dose escalating, multicentre titration study to assess the efficacy and safety of repeated subcutaneous administration of different doses of BIM 23A760 in patients with carcinoid syndrome Not Recruiting United Kingdom
A Phase 3, Randomized, Placebo-controlled, Multicenter, Double-blind Study to Evaluate the Safety and Efficacy of Telotristat Etiprate (LX1606) in Patients with Carcinoid Syndrome Not Recruiting United Kingdom
A Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea Not recruiting United Kingdom

Page last reviewed: 15/05/2015

Next review due: 01/05/2018